57Indexed trials
mesh condition
Drug Resistant Epilepsy
Intelligence
Drug Resistant Epilepsy intelligence: 57 indexed trials, 18 recruiting studies, 45 sponsors across 35 countries.
18Recruiting
45Sponsors
35Countries
Leading sponsors
Xuanwu Hospital, Beijing33 recruiting
Hospices Civils de Lyon31 recruiting
All India Institute of Medical Sciences20 recruiting
NaviFUS Corporation21 recruiting
UMC Utrecht21 recruiting
Beijing Tiantan Hospital20 recruiting
LivaNova20 recruiting
PTC Therapeutics20 recruiting
Assistance Publique Hopitaux De Marseille21 recruiting
Dartmouth-Hitchcock Medical Center21 recruiting
Brigham and Women's Hospital11 recruiting
Duke University11 recruiting
Geographic activity
United States17trials
France9trials
United Kingdom7trials
China7trials
Italy5trials
Canada4trials
Spain3trials
Netherlands3trials
Australia3trials
India3trials
Belgium3trials
Poland3trials
Leading interventions
NaviFUS System3trials
Perampanel2trials
SEEG recordings and SPES2trials
Vatiquinone2trials
BHV-70001trials
Blood Test1trials
Active Comparator Intervention (Music C)1trials
Cannabidiol (CBD) oral solution1trials
Advanced MRI1trials
Cathodal Transcranial Direct Current Stimulation (tDCS).1trials
Cedrus RB series response pad; Adtech Behnke-Fried micro-electrodes; Neuralynx or Blackrock electrophysiology system; Blackrock Cerestim or Natus Nicolet stimulator1trials
Cannabidiol1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.